Lanean...
FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development
BACKGROUND: The Office of Orphan Products Development (OOPD) of the United States (U.S.) Food and Drug Administration (FDA) has awarded over 700 grants to conduct clinical trials of medicals products for rare diseases since 1983, leading to over 70 marketing approvals. However, despite recent progre...
Gorde:
| Argitaratua izan da: | Orphanet J Rare Dis |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469294/ https://ncbi.nlm.nih.gov/pubmed/32883327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01514-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|